Paid Clinical Trials Hattiesburg

Discover 21 paid clinical trials in Hattiesburg, Mississippi. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 21

Fianlimab & CemiplimabA Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung Cancer

Recruiting

PHASE2

PHASE3

Sponsor:

Regeneron Pharmaceuticals

Location:

Hattiesburg MS, Baton Rouge LA, Germantown TN, Tallahassee FLshow 26 more

Code:

NCT05800015

Conditions

Non-small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

fianlimab

cemiplimab

Pemetrexed

Paclitaxel

Carboplatin

SonrotoclaxA Study to Investigate Efficacy and Safety of BCL2 Inhibitor Sonrotoclax as Monotherapy and in Combination With Zanubrutinib in Adults With Waldenström Macroglobulinemia

Recruiting

PHASE2

Sponsor:

BeiGene

Location:

Hattiesburg MS, Dallas TX, Charlotte NC, Miami FLshow 17 more

Code:

NCT05952037

Conditions

Waldenstrom Macroglobulinemia

Waldenstrom's Macroglobulinemia Recurrent

Waldenstrom's Macroglobulinemia Refractory

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Sonrotoclax

Zanubrutinib

LuspaterceptELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions

Recruiting

PHASE3

Sponsor:

Bristol-Myers Squibb

Location:

Hattiesburg MS, Covington LA, New Orleans LA, Baton Rouge LAshow 38 more

Code:

NCT05949684

Conditions

Myelodysplastic Syndromes

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Luspatercept

Epoetin Alfa

ZanubrutinibObservational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenström Macroglobulinemia

Recruiting

Sponsor:

BeiGene

Location:

Hattiesburg MS, Mobile AL, New Orleans LA, Huntsville ALshow 11 more

Code:

NCT05640102

Conditions

Waldenstrom Macroglobulinemia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Zanubrutinib

Venetoclax & ObinutuzumabStudy to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)

Recruiting

PHASE2

Sponsor:

AbbVie

Location:

Hattiesburg MS, Charlotte NC, Winston-Salem NC, Des Moines IAshow 7 more

Code:

NCT04895436

Conditions

Chronic Lymphocytic Leukemia (CLL)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Venetoclax

Obinutuzumab

Buccal Film vs. IV PalonosetronBuccal Film vs IV Palonosetron for Prevention of CINV in Cancer Patients Receiving MEC

Recruiting

PHASE3

Sponsor:

Xiamen LP Pharmaceutical Co., Ltd

Location:

Hattiesburg MS, Ocala FL, Savannah GA, Lakeland FLshow 8 more

Code:

NCT05199818

Conditions

Chemotherapy-induced Nausea and Vomiting

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Palonosetron HCl Buccal Film 0.5 mg

IV Palonosetron 0.25 mg

AmivantamabA Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer

Recruiting

PHASE1

PHASE2

Sponsor:

Janssen Research & Development, LLC

Location:

Hattiesburg MS, Birmingham AL, Nashville TN, Houston TXshow 11 more

Code:

NCT05379595

Conditions

Advanced or Metastatic Colorectal Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Amivantamab

Fluorouracil

Leucovorin

Oxaliplatin

Irinotecan

Iberdomide vs. LenalidomideA Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma

Recruiting

PHASE3

Sponsor:

Bristol-Myers Squibb

Location:

Hattiesburg MS, Germantown TN, Atlanta GA, Nashville TNshow 36 more

Code:

NCT05827016

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Iberdomide

Lenalidomide

JNJ-64042056A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease

Recruiting

PHASE2

Sponsor:

Janssen Pharmaceutica N.V., Belgium

Location:

Hattiesburg MS, Jacksonville FL, The Villages FL, Lady Lake FLshow 28 more

Code:

NCT06544616

Conditions

Preclinical Alzheimer's Disease

Eligibility Criteria

Sex: All

Age: 55 - 70+

Healthy Volunteers: Not accepted

Interventions

JNJ-64042056

Placebo

E2814 & LecanemabA Study of E2814 With Concurrent Lecanemab Treatment in Participants With Early Alzheimer's Disease

Recruiting

PHASE2

Sponsor:

Eisai Inc.

Location:

Hattiesburg MS, Columbus GA, Cordova TN, Dallas TXshow 21 more

Code:

NCT06602258

Conditions

Alzheimer's Disease

Eligibility Criteria

Sex: All

Age: 50 - 70+

Healthy Volunteers: Not accepted

Interventions

E2814

Lecanemab

Placebo